Meme Insider
Artelo Biosciences Adopts Solana Treasury Strategy with $9.5M Investment
Discover how Artelo Biosciences becomes the first publicly-traded pharma company to adopt Solana (SOL) as a core reserve asset with a $9.5M private placement.
Discover how Artelo Biosciences becomes the first publicly-traded pharma company to adopt Solana (SOL) as a core reserve asset with a $9.5M private placement.
Discover how Artelo Biosciences raised $9.475M to launch a Solana treasury strategy, becoming the first publicly traded pharma firm to adopt $SOL as a reserve asset.